Photobiomodulation (PBM) is a light-based therapy with over 5,000 published peer-reviewed studies — one of the most researched areas in regenerative medicine. It works through a simple but profound mechanism: specific wavelengths of red and near-infrared light are absorbed by mitochondrial photoreceptors (primarily cytochrome c oxidase), triggering increased ATP production, reduced oxidative stress, and activation of cellular repair pathways.
The ARC chamber delivers calibrated red (660nm) and near-infrared (850nm) light at therapeutic intensity to the entire body simultaneously — unlike small handheld devices that treat isolated areas. This whole-body approach produces systemic effects: reduced systemic inflammation, improved cellular energy throughout all tissues, enhanced hormonal signaling, and full-body muscle recovery.
The mechanism is well-established: cytochrome c oxidase (Complex IV of the mitochondrial electron transport chain) acts as a photoacceptor for red/NIR light. When activated, it produces 10x the normal ATP output, releases nitric oxide, reduces reactive oxygen species, and triggers gene expression changes associated with healing and repair.
Clinical applications with strong evidence include: athletic recovery and performance, joint pain and arthritis, wound healing, skin rejuvenation, testosterone support, sleep improvement, and neuroprotection. The ARC system delivers this broad range of benefits in a comfortable, non-invasive, zero-downtime session.